Observational Study Evaluating Outcomes of Hip Arthroplasty Using Tornier Dual Mobility Acetabular Cup

NCT ID: NCT02062450

Last Updated: 2017-05-04

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

379 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-05-31

Study Completion Date

2013-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to demonstrate the performance and reliability of Tornier "Dual Mobility Cup" used during primary total hip replacement or hip replacement revision surgery at least 24 months post-insertion.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The PURPOSE of this study is to demonstrate the performance and reliability of the Tornier "Dual Mobility Cup" used during primary total hip replacement or hip replacement revision surgery at a minimum of 24 months post-implantation. The primary endpoint is to determine the dislocation rate observed during post-surgical follow-up. The secondary endpoints are to assess, in the short-term, the following: clinical performance on the basis of clinical scores and hip mobility; radiological performance, particularly in terms of positioning and fixation of the implant; as well as the reliability of the implantation of this acetabular cup on the basis of any complications observed

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Primary Osteoarthritis Post-traumatic Osteoarthritis of Hip Nos Femur Head Necrosis Femur Neck Fracture Congenital Dislocations

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Primary surgery with Dual Mobility Cup

Patients having a Primary Hip acetabular replacement, using a Dual Mobility Cup.

Primary surgery with Dual Mobility Cup

Intervention Type DEVICE

Hip joint replacement with a hip prosthesis including a Dual Mobility cup to replace the acetabular component.

Revision surgery with Dual Mobility Cup

Patients having a Revision Hip acetabular replacement, using a Dual Mobility Cup.

Revision surgery with Dual Mobility Cup

Intervention Type DEVICE

Hip joint replacement with a hip prosthesis including a Dual Mobility cup to replace the acetabular component.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Primary surgery with Dual Mobility Cup

Hip joint replacement with a hip prosthesis including a Dual Mobility cup to replace the acetabular component.

Intervention Type DEVICE

Revision surgery with Dual Mobility Cup

Hip joint replacement with a hip prosthesis including a Dual Mobility cup to replace the acetabular component.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* men and women aged over 18, undergoing total hip replacement with insertion of a Dual Mobility acetabular cup between October 2010 and October 2011,
* capable of attending the 2-year follow-up visit;
* capable of understanding the information about the study and agreeing to take part in it.

Exclusion Criteria

* patients with tumoral pathology.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Stryker Trauma and Extremities

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Christophe Hulet, MD, PR

Role: PRINCIPAL_INVESTIGATOR

Caen University Hospital, FR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1204-T-DOUBLEMOB-RM

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.